Back to BlackRock, Inc. BlackRock, Inc.

RCKTRCKT
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ROCKET PHARMACEUTICALS INC

BlackRock, Inc. holds 9.9M shares of RCKT (ROCKET PHARMACEUTICALS INC), worth $33.9M as of 2026-Q2. The position was increased (+26.7% shares). RCKT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$33.9M

Current Shares

9.9M

Total Value Change

-$83.7M

Total Shares Change

+3.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
9.9M
+26.7%
$33.9M0.0%$3.42
36
2026-Q1
Decreased
7.8M
-0.9%
$28M0.0%$3.58
0
2025-Q4
Increased
7.9M
+11.1%
$27.8M0.0%$3.51
32
2025-Q3
Decreased
7.1M
-4.2%
$23.2M0.0%$3.26
0
2025-Q2
Increased
7.4M
+2.1%
$18.2M0.0%$2.45
29
2025-Q1
Increased
7.3M
+2.5%
$48.5M0.0%$6.67
30
2024-Q4
Increased
7.1M
+11.4%
$89.2M0.0%$12.57
33
2024-Q3
First report
6.4M
-
$117.7M0.0%$18.47
0

Other major holders of RCKT: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used